We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Resources to learn more about and promote Analysis in Government (AiG) Month
How to use a cost utility analysis to evaluate your digital health product.
How to use an ethnographic study to evaluate your digital health product.
How to use a cost effectiveness analysis to evaluate your digital health product.
This guide outlines how people working in international development can use a set of analytical tools collectively known as 'political economy analysis' (PEA).
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
How to use a cost benefit analysis to evaluate your digital health product.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
A speech by Sarah Cardell, CEO of the Competition and Markets Authority (CMA), delivered at the CMA's 10 year anniversary event.
This report assessed whether, and how, the existing evidence base on the impact of trade promotion activities could be strengthened through further robust econometric analysis.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
The Regulatory Policy Committee provides the government with external, independent scrutiny of the evidence supporting changes in law that affect businesses, charities and community groups.
How to use a behaviour change techniques review to evaluate your digital health product.
How to prepare and analyse the data you collected for your evaluation.
Using an ecological momentary assessment to evaluate your digital health product.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.
How to use a quasi-experimental study to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).